Analysts expect Spyre Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 3.38 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Low Estimate | 0.00 | 3.01 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Consensus Estimate | 0.00 | 3.19 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analysts expect Spyre Therapeutics, Inc. to report earnings per share of -0.82 for Q3 26, against a range of -0.85 to -0.79. The most recent reported quarter, Q2 26, came in at -0.36, a 55.0% beat against the -0.80 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.36 | -0.81 | -0.60 | -0.49 | -0.15 | -0.70 | -0.74 | -0.36 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.71 | -0.96 | -0.73 | -0.66 | -0.67 | -0.66 | -0.67 | -0.73 | -0.79 | -0.72 | -0.73 | -0.75 | -0.85 | -0.83 | -1.06 | -0.94 | ||||||||||
| Low Estimate | -0.87 | -1.08 | -0.85 | -0.80 | -0.77 | -0.72 | -0.75 | -0.87 | -0.85 | -0.80 | -0.85 | -0.85 | -0.93 | -0.95 | -1.16 | -1.10 | ||||||||||
| Consensus Estimate | -0.79 | -1.02 | -0.79 | -0.73 | -0.72 | -0.69 | -0.71 | -0.80 | -0.82 | -0.76 | -0.79 | -0.80 | -0.89 | -0.89 | -1.11 | -1.02 |
Pull Wall Street consensus for Spyre Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=SYRE&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "SYRE", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=SYRE&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();